US Stock MarketDetailed Quotes
INVO INVO Bioscience
- 1.1200
- -0.1000-8.20%
Close May 14 16:00 ET
- 1.1203
- +0.0003+0.03%
Post 19:35 ET
4.25MMarket Cap-218P/E (TTM)
1.1800High1.0800Low268.15KVolume1.1400Open1.2200Pre Close298.83KTurnover7.12%Turnover RatioLossP/E (Static)3.80MShares8.600052wk High-0.83P/B4.22MFloat Cap0.500052wk Low--Dividend TTM3.77MShs Float246.0000Historical High--Div YieldTTM8.20%Amplitude0.5000Historical Low1.1140Avg Price1Lot Size
INVO Bioscience Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 267.38%3.02M | 396.78%1.38M | 314.28%974.89K | 116.17%315.9K | 114.04%348.03K | -80.24%822.2K | -90.88%278.14K | 7.51%235.32K | -29.90%146.14K | -76.25%162.6K |
| Operating revenue | 267.38%3.02M | 396.78%1.38M | 314.28%974.89K | 116.17%315.9K | 114.04%348.03K | -80.24%822.2K | -90.88%278.14K | 7.51%235.32K | -29.90%146.14K | -76.25%162.6K |
| Cost of revenue | 127.37%1.93M | 278.01%886.75K | 133.34%580.97K | 32.61%255.42K | 11.69%72.55K | 486.53%850.77K | 396.02%234.59K | 1,119.40%248.98K | 1,219.69%192.61K | 3.53%64.96K |
| Gross profit | 3,901.14%1.09M | 1,036.48%495K | 2,984.64%393.93K | 230.14%60.48K | 182.14%275.47K | -100.71%-28.57K | -98.55%43.56K | -106.88%-13.66K | -123.97%-46.47K | -84.30%97.64K |
| Operating expense | -25.90%7.85M | -27.46%2M | -49.03%1.28M | -19.31%2.13M | -7.74%2.58M | 14.80%10.6M | 10.59%2.76M | 1.60%2.51M | 26.67%2.64M | 28.28%2.8M |
| Selling and administrative expenses | -24.96%7.49M | -30.44%1.86M | -45.74%1.26M | -16.44%2.04M | -6.90%2.51M | 10.66%9.98M | 9.63%2.67M | -4.14%2.32M | 19.28%2.44M | 27.38%2.69M |
| Research and development costs | -69.50%165.95K | -92.00%5.91K | -98.48%2.67K | -56.04%83.85K | -29.43%73.52K | 151.37%544.04K | 15.81%73.84K | 216.42%175.27K | 515.04%190.76K | 57.21%104.18K |
| Depreciation amortization depletion | 159.89%200.89K | 610.12%141.6K | 3.91%20.5K | ---- | ---- | --77.3K | --19.94K | --19.73K | ---- | ---- |
| -Depreciation and amortization | 159.89%200.89K | 610.12%141.6K | 3.91%20.5K | ---- | ---- | --77.3K | --19.94K | --19.73K | ---- | ---- |
| Operating profit | 36.32%-6.77M | 44.51%-1.51M | 64.91%-886.29K | 22.96%-2.07M | 14.61%-2.31M | -103.71%-10.63M | -639.82%-2.72M | -11.07%-2.53M | -42.15%-2.68M | -73.16%-2.7M |
| Net non-operating interest income expense | -1,465.70%-925.91K | -224.35%-182.04K | -20,287.09%-352.09K | -324,329.63%-175.19K | -17,494.56%-216.59K | 95.31%-59.14K | 69.89%-56.13K | 98.15%-1.73K | 99.94%-54 | 99.86%-1.23K |
| Non-operating interest income | --0 | --0 | --0 | --0 | --0 | -91.58%308 | -98.39%1 | --34 | -98.02%48 | -88.82%225 |
| Non-operating interest expense | 1,457.59%925.91K | 224.35%182.04K | 19,893.47%352.09K | 171,656.86%175.19K | 14,775.62%216.59K | -95.30%59.45K | -69.90%56.13K | -98.11%1.76K | -99.89%102 | -99.84%1.46K |
| Other net income (expense) | -53.79%-313.76K | -3,071.01%-281.24K | 63.61%-8.18K | 102.96%3.52K | 61.37%-27.87K | -18.65%-204.02K | 104.40%9.47K | 80.32%-22.48K | -175.19%-118.87K | -15,448.06%-72.14K |
| Gain on sale of security | 87.87%-420 | 99.26%-4 | 98.41%-16 | 70.16%-265 | 86.84%-135 | 2.01%-3.46K | 59.05%-541 | -39.81%-1.01K | 13.62%-888 | -121.12%-1.03K |
| Earnings from equity interest | 69.95%-60.27K | -381.40%-28.16K | 61.98%-8.16K | 103.21%3.79K | 61.00%-27.74K | 38.77%-200.56K | 104.68%10.01K | 81.08%-21.47K | ---117.98K | ---71.12K |
| Special income (charges) | ---253.07K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Less:Other special charges | --163.28K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Write off | --89.79K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Income before tax | 26.47%-8.01M | 28.69%-1.97M | 51.11%-1.25M | 20.11%-2.24M | 8.05%-2.55M | -63.75%-10.89M | -2,816.55%-2.76M | -2.75%-2.55M | -54.13%-2.8M | -13.08%-2.77M |
| Income tax | 867.48%27.79K | 1,011.73%23.04K | 1.89K | 258.13%2.87K | -39.71%2.87K | -56.51%2.07K | 0 | 800 | ||
| Net income | 26.24%-8.03M | 27.91%-1.99M | 51.03%-1.25M | 20.03%-2.24M | 8.05%-2.55M | -63.68%-10.89M | -2,952.08%-2.77M | -2.75%-2.55M | -54.17%-2.8M | -13.08%-2.77M |
| Net income continuous Operations | 26.24%-8.03M | 27.91%-1.99M | 51.03%-1.25M | 20.03%-2.24M | 8.05%-2.55M | -63.68%-10.89M | -2,952.08%-2.77M | -2.75%-2.55M | -54.17%-2.8M | -13.08%-2.77M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 26.24%-8.03M | 27.91%-1.99M | 51.03%-1.25M | 20.03%-2.24M | 8.05%-2.55M | -63.68%-10.89M | -1,855.16%-2.77M | -13.68%-2.55M | -54.17%-2.8M | -13.08%-2.77M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 26.24%-8.03M | 27.91%-1.99M | 51.03%-1.25M | 20.03%-2.24M | 8.05%-2.55M | -63.68%-10.89M | -1,855.16%-2.77M | -13.68%-2.55M | -54.17%-2.8M | -13.08%-2.77M |
| Basic earnings per share | 71.45%-5.13 | 82.41%-0.8003 | 83.29%-0.7 | 33.77%-3.06 | 13.04%-4 | -42.62%-17.97 | -858.33%-4.55 | 12.71%-4.19 | -35.88%-4.62 | 8.00%-4.6 |
| Diluted earnings per share | 71.45%-5.13 | 82.41%-0.8003 | 83.29%-0.7 | 33.77%-3.06 | 13.04%-4 | -42.62%-17.97 | -858.33%-4.55 | 12.71%-4.19 | -35.88%-4.62 | 8.00%-4.6 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
